NEW YORK (
CHANGE IN RATINGS
downgraded at BofA/Merrill from Buy to Underperform, Bank of America/Merrill Lynch said. Margin expansion could take longer than expected. $13.50 price target.
(CHK - Get Report)
downgraded at Brean from Buy to Hold, Brean Murray said. Company is leveraged to lower natural gas prices.
(CREE - Get Report)
downgraded at Ticonderoga from Buy to Neutral, Ticonderoga said. Company is seeing lower margins and lacks sales visibility.
Cree upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $30 price target. Valuation call, based on a $30 price target.
downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $50 price target. Company is facing higher credit costs and narrower margins.
downgraded at UBS to Neutral from Buy, UBS said. $46 price target. Subscriber growth likely to slow.
rated new Buy at ThinkEquity. $100 price target. Sapien catheter should drive near-term growth.
(EXPE - Get Report)
rated new Underweight at JP Morgan. $31 price target. Company is facing increased competition.
(GES - Get Report)
downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $29 price target. Company faces currency headwinds.
(GOOG - Get Report)
downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Company faces several potential growth headwinds.
Hudson City Bancorp
downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Stock appears fully valued at current levels.
downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $25 price target.
downgraded at Keybanc from Buy to Hold, Keybanc said. Mild weather is hurting HVAC demand.
upgraded at Credit Suisse from Underperform to Neutral, Credit Suisse said. $13 price target. Strip activity is showing steady gains.
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $63 price target.
downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Company faces earnings headwinds in the new year.
rated new Neutral at Credit Suisse. $72 price target. Company remains highly leveraged to declining department store traffic.